Global Synthetic Biology Market Size By Type (Gene Synthesis, Genome Engineering), By Application (Medical Applications, Industrial Applications), By Region, And Segment Forecasts, 2023 to 2032

The Global Synthetic Biology Market was valued at USD 14.5 billion in 2023 and is projected to reach USD 45.2 billion by 2031, growing at a CAGR of 15.4% during the forecast period of 2023-2031. Synthetic biology is revolutionizing multiple industries, including healthcare, agriculture, energy, and environmental sciences, by enabling the design and construction of new biological parts, devices, and systems. The growing demand for sustainable and innovative biotechnological solutions, advancements in genome editing technologies, and increasing investment in synthetic biology research are key drivers propelling the market forward.

Drivers

Advancements in Genetic Engineering and Genome Editing

The rapid development of CRISPR-Cas9 and other gene-editing technologies is accelerating innovation in synthetic biology. These tools have enabled precise genetic modifications, boosting research and commercialization of genetically engineered organisms in medicine, agriculture, and bio-manufacturing.

Rising Demand for Bio-Based Products

Consumers and industries are shifting towards bio-based alternatives in response to environmental concerns. Synthetic biology is at the forefront of producing sustainable biofuels, biodegradable plastics, and bio-based chemicals, reducing reliance on fossil fuels and non-renewable resources.

Growing Investments and Government Support

Government initiatives and funding for synthetic biology research are increasing worldwide. Countries such as the U.S., China, and the U.K. are investing heavily in synthetic biology projects, supporting start-ups and academic research to accelerate market growth.

Restraints

Ethical and Biosafety Concerns

The genetic modification of organisms raises ethical questions and biosafety concerns. The potential risks associated with the release of synthetic organisms into the environment and the misuse of gene-editing technology pose significant regulatory challenges.

High Cost of Research and Development

Despite technological advancements, the cost of synthetic biology research, including DNA synthesis, genome editing, and bioprocess development, remains high. This limits accessibility for small and mid-sized enterprises.

Opportunities

Personalized Medicine and Synthetic Biology Applications in Healthcare

Synthetic biology is playing a crucial role in personalized medicine by enabling the development of tailored gene therapies, synthetic vaccines, and customized drug production. The growing interest in synthetic biology for disease treatment presents significant opportunities.

Expansion of Agricultural Biotechnology

The increasing need for sustainable food production is driving the application of synthetic biology in agriculture. Genetically engineered crops with enhanced resistance to pests, improved nutritional content, and reduced dependency on chemical fertilizers are gaining traction.

Development of Synthetic Microorganisms for Industrial Applications

Biotechnology firms are developing synthetic microbes for industrial applications, including wastewater treatment, biofuel production, and carbon sequestration. These innovations are expanding the potential of synthetic biology in environmental sustainability.

Market by System Type Insights

Based on system type, the Genetic Circuits segment accounted for the largest market share in 2023. Genetic circuits are widely used in synthetic biology applications, including biosensors, metabolic engineering, and synthetic gene networks. The segment is expected to maintain its dominance due to increasing applications in healthcare and bio-manufacturing.

The DNA Synthesis & Sequencing segment is projected to grow at the highest CAGR, driven by technological advancements in gene synthesis, automation in DNA sequencing, and declining costs.

Market by End-Use Insights

In terms of end-use, the Healthcare & Pharmaceuticals segment emerged as the largest revenue contributor in 2023, accounting for over 40% of the market share. Synthetic biology plays a critical role in drug discovery, synthetic vaccine production, and cell therapy, fueling its adoption in the pharmaceutical industry.

The Agriculture & Food Industry segment is expected to witness the highest growth during the forecast period. The rising demand for genetically engineered crops, lab-grown meat, and bio-based fertilizers is driving the adoption of synthetic biology in agriculture.

Market by Regional Insights

North America

North America dominated the global synthetic biology market in 2023, accounting for the largest share due to strong research and development infrastructure, high investment in biotechnology, and the presence of key market players in the region.

Asia-Pacific

The Asia-Pacific region is projected to register the highest CAGR during the forecast period. Countries like China, India, and Japan are investing heavily in synthetic biology research, and the increasing adoption of bio-based products is driving market growth.

Europe

Europe also holds a substantial share in the synthetic biology market, supported by favorable government policies, academic research initiatives, and the rising demand for bio-based chemicals and sustainable agricultural solutions.

Competitive Scenario

Key players operating in the Global Synthetic Biology Market include:

Thermo Fisher Scientific

Twist Bioscience

Codexis, Inc.

Ginkgo Bioworks

Synthetic Genomics Inc.

Zymergen Inc.

Precigen, Inc.

Integrated DNA Technologies, Inc.

New England Biolabs

Novozymes A/S

These companies are focusing on strategic collaborations, mergers & acquisitions, and technological advancements to strengthen their market position.

Scope of Work – Global Synthetic Biology Market

Report Metric Details

Market Size (2023) USD 14.5 billion

Projected Market Size (2031) USD 45.2 billion

CAGR (2023-2031) 15.4%

Key Segments by System Type Genetic Circuits, DNA Synthesis & Sequencing

Key Segments by End-Use Healthcare & Pharmaceuticals, Agriculture & Food Industry

Leading Region North America

Key Players Thermo Fisher Scientific, Twist Bioscience, Codexis, Ginkgo Bioworks, Synthetic Genomics, Zymergen, Precigen, and more

Key Market Developments

March 2023: Twist Bioscience launched a new synthetic DNA library designed to accelerate synthetic biology applications in healthcare and industrial biotechnology.

July 2023: Ginkgo Bioworks partnered with a leading pharma company to develop synthetic biology-based gene therapies.

October 2023: Codexis announced the expansion of its enzyme engineering platform to develop sustainable bio-based chemicals for the industrial sector.

January 2024: Synthetic Genomics developed a new synthetic microorganism capable of improving carbon sequestration in environmental applications.

FAQs

1. What is the current market size of the Global Synthetic Biology Market?

The Global Synthetic Biology Market was valued at USD 14.5 billion in 2023 and is expected to grow significantly during the forecast period.

2. What is the major growth driver of the Global Synthetic Biology Market?

The major growth drivers include advancements in genetic engineering, increasing demand for bio-based products, and rising investments in synthetic biology research.

3. Which is the largest region during the forecast period in the Global Synthetic Biology Market?

North America held the largest market share in 2023 due to strong research infrastructure and investments in synthetic biology technologies.

4. Which segment accounted for the largest market share in the Global Synthetic Biology Market?

The Genetic Circuits segment accounted for the largest market share, driven by its applications in synthetic gene networks, biosensors, and metabolic engineering.

5. Who are the key market players in the Global Synthetic Biology Market?

Key market players include Thermo Fisher Scientific, Twist Bioscience, Codexis, Ginkgo Bioworks, Synthetic Genomics, Zymergen, Precigen, Integrated DNA Technologies, and Novozymes.

This comprehensive report provides an in-depth analysis of the market trends, key drivers, competitive landscape, and future growth opportunities in the Global Synthetic Biology Market.